title: Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man's land?
authors: Richard
authors: R
authors: Naspro
authors: Roberta
authors: R
authors: Rossini
authors: Giuseppe
authors: G
authors: Musumeci
authors: Franco
authors: F
authors: Gadda
authors: Luigi Filippo Da
authors: LF
authors: Pozzo
mesh_terms: D003328:Coronary Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D004334:Drug Administration Schedule; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D018579:Patient Selection; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000295:instrumentation*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D018570:Risk Assessment; D012307:Risk Factors; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome; D013520:Urologic Surgical Procedures / Q000009:adverse effects
chemical_list: D010975:Platelet Aggregation Inhibitors